These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 535711)

  • 1. [Hepatic drug metabolism in patients with intrahepatic cholestasis (author's transl)].
    Deschamps JP; Miguet JP; Vuitton D; Joanne C; Allemand H; Carayon P; Bechtel P; Gisselbrecht H
    Gastroenterol Clin Biol; 1979 May; 3(5):439-45. PubMed ID: 535711
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholestasis and hepatic drug metabolism. Comparison of metabolic clearance rate of antipyrine in patients with intrahepatic or extrahepatic cholestasis.
    Miguet JP; Vuitton D; Deschamps JP; Allemand H; Joanne C; Bechtel P; Carayon P
    Dig Dis Sci; 1981 Aug; 26(8):718-22. PubMed ID: 7261836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of hepatic drug metabolism in patients with Budd-Chiari syndrome.
    Narang AP; Datta DV; Mathur VS
    Indian J Med Res; 1982 Apr; 75():567-73. PubMed ID: 7106896
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug metabolism in patients with liver disease (author's transl)].
    Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
    Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The metabolic clearance rate of antipyrine: a good index for the assessment of the hepatic drug-oxidizing function in cirrhotic patients (author's transl)].
    Miguet JP; Allemand H; Joanne C; Dhumeaux D
    Nouv Presse Med; 1978 Dec; 7(46):4209-11. PubMed ID: 745958
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of the cholestatic factor in the liver tissue of patients with acute intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Sakagami Y; Yamamoto S; Morisawa S
    Ann Allergy; 1986 Apr; 56(4):304-7. PubMed ID: 3516021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic metabolism of antipyrine in patients with acute pancreatitis].
    Lukaszyk A
    Przegl Lek; 1987; 44(2):273-6. PubMed ID: 3615930
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver failure and drug metabolism.
    Andreasen PB; Ranek L
    Scand J Gastroenterol; 1975; 10(3):293-7. PubMed ID: 1138332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
    Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
    Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The differential diagnosis of cholestasis (author's transl)].
    Tison V; Callea F
    Pathologica; 1980; 72(1019):359-82. PubMed ID: 7465265
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of short-term administration of ibuprofen on trimethadione metabolism and antipyrine metabolite formation in the rat.
    Tanaka E; Kobayashi S; Oguchi K; Kuroiwa Y; Yasuhara H
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):317-20. PubMed ID: 4023417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progressive intrahepatic cholestasis (author's transl)].
    Rotthauwe HW; Becker M; Bosch C
    Monatsschr Kinderheilkd; 1981 Sep; 129(9):515-20. PubMed ID: 7343828
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis-1 deficiency manifesting progressive familial intrahepatic cholestasis.
    Nagasaka H; Yorifuji T; Hirano K; Ota A; Toyama-Nakagawa Y; Takatani T; Tsukahara H; Kobayashi K; Takayanagi M; Inomata Y; Uemoto S; Miida T
    Metabolism; 2009 Jan; 58(1):48-54. PubMed ID: 19059530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intrahepatic cholestasis due to biochemical errors of bile acids. II. Clinical and therapeutic aspects].
    Lovisetto P; Raviolo P
    Minerva Med; 1994 Dec; 85(12):639-46. PubMed ID: 7854557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation.
    Sonne J; Døssing M; Poulsen HE; Pilsgaard H; Rasmussen B; Loft S
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):194-6. PubMed ID: 3583468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Place of gammaglutamyltransferase among the indirect procedures of evaluation of the function of enzymes of drug metabolism (author's transl)].
    Siest G; Ratanasavanh D; Bagrel D; Tazi A; Galteau MM
    Ann Biol Clin (Paris); 1980; 38(1):67-73. PubMed ID: 6103683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.